We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
MacroGenics
MGNX
$255M
| $11.8M | 0.02% |
+370,000
| New | +$8.99M |
|
|
IEA
627
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $11.7M | 0.02% |
+720,000
| New | +$13M |
|
628
Cboe Global Markets
CBOE
$30.2B
| $11.7M | 0.02% |
118,500
+4,900
| +4% | +$478K |
|
629
Black Hills Corp
BKH
$5.54B
| $11.7M | 0.02% |
174,801
+100,000
| +134% | +$6.21M |
|
|
POW
630
DELISTED
Powered Brands Class A Ordinary Shares
POW
| $11.7M | 0.02% |
+1,200,000
| New | +$11.7M |
|
|
FOXO
631
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
| $11.6M | 0.02% |
+6,030
| New | +$11.9M |
|
632
Evercore
EVR
$12B
| $11.6M | 0.02% |
87,883
+57,481
| +189% | +$7.02M |
|
633
Iron Mountain
IRM
$36.3B
| $11.6M | 0.02% |
312,352
+108,900
| +54% | +$3.64M |
|
634
Pentair
PNR
$11.2B
| $11.5M | 0.02% |
184,943
-132,351
| -42% | -$7.59M |
|
635
FerroAtlántica
GSM
$772M
| $11.5M | 0.02% |
3,029,376
-4,212,016
| -58% | -$12.5M |
|
636
Universal Health Services
UHS
$10.3B
| $11.3M | 0.02% |
84,659
-1,600
| -2% | -$212K |
|
637
Cenovus Energy
CVE
$52.1B
| $11.3M | 0.02% |
1,500,000
-4,050,000
| -73% | -$28.5M |
|
|
CUTR
638
DELISTED
Cutera, Inc.
CUTR
| $11.3M | 0.02% |
375,000
-28,000
| -7% | -$828K |
|
|
FACA.U
639
DELISTED
Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
FACA.U
| $11.3M | 0.02% |
+1,111,771
| New | +$11.7M |
|
640
Expeditors International
EXPD
$23.2B
| $11.1M | 0.02% |
103,400
-83,500
| -45% | -$8.04M |
|
641
Warrior Met Coal
HCC
$4.73B
| $11.1M | 0.02% |
650,000
+300,000
| +86% | +$6.33M |
|
642
Newell Brands
NWL
$2.56B
| $11.1M | 0.02% |
414,400
+152,600
| +58% | +$3.79M |
|
643
News Corp Class A
NWSA
$16.1B
| $11M | 0.02% |
433,110
-2,096
| -0.5% | -$47K |
|
644
Pulmonx
LUNG
$88M
| $10.9M | 0.02% |
239,052
+45,109
| +23% | +$2.59M |
|
645
Outfront Media
OUT
$5.48B
| $10.9M | 0.02% |
+507,988
| New | +$10.4M |
|
646
EPAM Systems
EPAM
$4.86B
| $10.9M | 0.02% |
27,500
-2,500
| -8% | -$915K |
|
647
Western Union
WU
$2.23B
| $10.9M | 0.02% |
440,334
+382,385
| +660% | +$9M |
|
648
Norwegian Cruise Line
NCLH
$8.89B
| $10.8M | 0.02% |
392,500
+47,400
| +14% | +$1.26M |
|
649
CF Industries
CF
$17.9B
| $10.8M | 0.02% |
238,422
-751,621
| -76% | -$34M |
|
650
Palladyne AI
PDYN
$278M
| $10.8M | 0.02% |
+183,333
| New | +$10.7M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.